ATR and urothelial carcinoma: These findings suggest that Wee1 inhibition leads to the activation of the DNA damage response pathway (ATR and ATM), which prompted us to use the combination of ATR or ATM with Wee1 inhibition to enhance the cytotoxicity of urothelial carcinoma.